5/10
03:40 pm
crnx
Crinetics Pharmaceuticals, Inc. (NASDAQ: CRNX) had its "buy" rating re-affirmed by analysts at HC Wainwright. They now have a $60.00 price target on the stock.
Low
Report
Crinetics Pharmaceuticals, Inc. (NASDAQ: CRNX) had its "buy" rating re-affirmed by analysts at HC Wainwright. They now have a $60.00 price target on the stock.
5/10
01:37 pm
crnx
Crinetics Pharmaceuticals, Inc. (NASDAQ: CRNX) had its "market outperform" rating re-affirmed by analysts at JMP Securities. They now have a $80.00 price target on the stock.
Low
Report
Crinetics Pharmaceuticals, Inc. (NASDAQ: CRNX) had its "market outperform" rating re-affirmed by analysts at JMP Securities. They now have a $80.00 price target on the stock.
5/10
01:37 pm
crnx
Crinetics Pharmaceuticals, Inc. (NASDAQ: CRNX) had its "market outperform" rating re-affirmed by analysts at JMP Securities. They now have a $80.00 price target on the stock.
Low
Report
Crinetics Pharmaceuticals, Inc. (NASDAQ: CRNX) had its "market outperform" rating re-affirmed by analysts at JMP Securities. They now have a $80.00 price target on the stock.
5/10
12:43 pm
crnx
Rating for CRNX
Low
Report
Rating for CRNX
5/10
12:43 pm
crnx
Rating for CRNX
Low
Report
Rating for CRNX
3/28
10:35 am
crnx
Rating for CRNX
Report
Rating for CRNX
3/28
10:35 am
crnx
Rating for CRNX
Report
Rating for CRNX
3/20
11:51 am
crnx
Rating for CRNX
Medium
Report
Rating for CRNX
3/20
11:51 am
crnx
Rating for CRNX
Medium
Report
Rating for CRNX
3/20
09:33 am
crnx
Rating for CRNX
Medium
Report
Rating for CRNX
3/20
09:33 am
crnx
Rating for CRNX
Medium
Report
Rating for CRNX
3/19
12:33 pm
crnx
Crinetics Pharmaceuticals, Inc. (NASDAQ: CRNX) had its "buy" rating re-affirmed by analysts at HC Wainwright. They now have a $50.00 price target on the stock.
Low
Report
Crinetics Pharmaceuticals, Inc. (NASDAQ: CRNX) had its "buy" rating re-affirmed by analysts at HC Wainwright. They now have a $50.00 price target on the stock.
3/18
03:16 pm
crnx
Crinetics Pharmaceuticals, Inc. (NASDAQ: CRNX) had its "buy" rating re-affirmed by analysts at HC Wainwright. They now have a $50.00 price target on the stock.
Low
Report
Crinetics Pharmaceuticals, Inc. (NASDAQ: CRNX) had its "buy" rating re-affirmed by analysts at HC Wainwright. They now have a $50.00 price target on the stock.
3/18
03:16 pm
crnx
Crinetics Pharmaceuticals, Inc. (NASDAQ: CRNX) had its "outperform" rating re-affirmed by analysts at Oppenheimer Holdings Inc.. They now have a $54.00 price target on the stock, up previously from $48.00.
Low
Report
Crinetics Pharmaceuticals, Inc. (NASDAQ: CRNX) had its "outperform" rating re-affirmed by analysts at Oppenheimer Holdings Inc.. They now have a $54.00 price target on the stock, up previously from $48.00.
3/13
11:23 am
crnx
Rating for CRNX
Low
Report
Rating for CRNX
3/13
11:23 am
crnx
Rating for CRNX
Low
Report
Rating for CRNX
3/13
08:33 am
crnx
Rating for CRNX
Low
Report
Rating for CRNX
3/13
08:33 am
crnx
Rating for CRNX
Low
Report
Rating for CRNX
3/6
07:18 am
crnx
Crinetics Pharmaceuticals, Inc. (NASDAQ: CRNX) is now covered by analysts at Citigroup Inc.. They set a "buy" rating and a $68.00 price target on the stock.
Low
Report
Crinetics Pharmaceuticals, Inc. (NASDAQ: CRNX) is now covered by analysts at Citigroup Inc.. They set a "buy" rating and a $68.00 price target on the stock.
3/6
05:18 am
crnx
Rating for CRNX
Low
Report
Rating for CRNX
3/6
05:18 am
crnx
Rating for CRNX
Low
Report
Rating for CRNX
3/4
10:27 am
crnx
Rating for CRNX
Low
Report
Rating for CRNX
2/29
02:17 pm
crnx
Rating for CRNX
Low
Report
Rating for CRNX
2/29
02:17 pm
crnx
Rating for CRNX
Low
Report
Rating for CRNX
2/29
10:38 am
crnx
Rating for CRNX
Medium
Report
Rating for CRNX